Out in JNCI! Rationale and design effectiveness-implementation trials for Systematic Symptom Management in the IMPACT Consortium. #PROs

Read more here: oxford.ly/3WkAtWh

A systematic review of 20 #RCTs of Antibody-Drug Conjugates by Suzuki et al. shows some increased adverse events like fatigue, nausea, and neuropathy, but no increase in febrile neutropenia. Toshiki Kuno, MD, PhD, FESC, FSCAI

Read more here: oxford.ly/3Ur71fA

Out in JNCI! Cascade testing using multigene panels for hereditary cancer can identify unexpected actionable findings in relatives of patients with cancer. #riskreduction #hereditarycancer Invitae

Read more here: oxford.ly/49LEPJ4

A study by Egemen et al. discusses an approach for developing effective #AI -based image recognition algorithms for medical screening and diagnostics, including cervical cancer screening. Didem Egemen Cancer Epi & Genetics

Read more: oxford.ly/4d5spP6

A study published in the Journal of the National Cancer Institute (JNCI) examined processes for identifying #caregivers and screening for distress management in community oncology. #cancersupport

Read it here: oxford.ly/3U44s1U

A study investigating racial and ethnic disparities in genomic testing among U.S. lung cancer patients found that testing was lower among Black patients than White or Asian patients.
#healthequity Duke Department of Medicine

Read now: oxford.ly/3W3ydlS

Published in JNCI: a trial emulation study using Danish observational data found surgery to be superior to chemotherapy for treatment of early stage #pancreaticcancer .

Read more: oxford.ly/4bjsgG7

A meta-analysis looks at the effectiveness of oral progestins or levonorgestrel-releasing IUD for #premenopausal women with endometrial intraepithelial neoplasia, showing the rate of pregnancy after treatment to be modest.

Read now: oxford.ly/4aRyYCS

A study by Coronado et al. discusses the need to maximize colorectal screening processes when resources are scarce by increasing the use of stool-based testing. #CRC #crcsm

Read now: oxford.ly/4cXllnD

.JNCI has launched a call for papers to investigate how social determinants of health impact cancer care and outcomes. The deadline for submissions is August 1, 2024.

Share your manuscript today: oxford.ly/3VKP7Wo

A study by Coronado et al. discusses the need to maximize colorectal screening processes when resources are scarce by increasing the use of stool-based testing. #CRC #crcsm

Read now: oxford.ly/4d4Js3v

Now out in JNCI! A study by Gibbs et al. investigated genetic variants in the vitamin D-binding protein gene (GC) and their association with melanoma-specific death. #Melanoma

Read more here: oxford.ly/4ajoUTg

In a Swedish cohort study, Schiza et al. noted comparable features in the incidence and prognosis of de novo metastatic breast cancer between women and men, suggesting that common treatments can be adopted.

Read here: oxford.ly/4aywF7u

Out today in JNCI: Study led by Isaac Ergas & Marilyn Kwan using data from Kaiser Permanente Research NorCal KPNorthernCal Pathways Study of #breastcancer #survivorship finds American Heart Association #DASH diet best for heart health.
#bcsm #heartdisease

Story: ibit.ly/twBPx

Now out in JNCI! In a survey study by Chido-Amajuoyi et al., healthcare professionals revealed reasons patients cite for not initiating or completing HPV vaccination. MD Anderson Cancer Center #HPV #PatientEducation

Read here: oxford.ly/3U2ySTu

Lu et al. reported treatment with G-quadruplex ligands that suppress c-FOS expression, in combination with #osimertinib , offers a potential strategy to inhibit osimertinib-resistant non-small cell lung cancer.

Read more here: oxford.ly/4aa7b0A

Commentary by Espinel et al. discusses the need for cancer centers to lead in advancing knowledge on disaster preparedness, especially during the era of #ClimateChange .

Read now: oxford.ly/3xaYsfL

An Association of American Cancer Institutes study shows a decrease in interventional treatment trial accruals during the #COVID19 pandemic and recovery, but innovative practices such as remote monitoring and consenting have facilitated patient access to trials.

Learn more: oxford.ly/4cx9VGQ

Now out in JNCI! A study by Brundage et al. investigated cancer patients' attitudes towards treatments offering progression-free survival (PFS) gains without overall survival (OS) gains. #CancerCare #OpenAccess

Read here: oxford.ly/4crV9Bf

Research in JNCI by Gradissimo et al. presents a novel HPV and host DNA methylation score for cervical adenocarcinoma screening. #CervicalCancer

Read here: oxford.ly/3PFwsrc